COVID-19

News

Italian 'chatbot' predicted COVID-19 spikes, says study

An online tool used by people in Italy to manage their potential exposure to COVID-19 using a simple chat interface has shown that it can spot emerging trends days ahead of the national sur

R&D

Targeting COVID-19 and cancer with immunotherapy advancement...

Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform.

News

FDA schedules adcomm for Pfizer's COVID booster filing

The FDA will hold an advisory committee meeting later this month to discuss Pfizer and BioNTech's filing for approval of a third booster dose of their COVID-19 vaccine Comirnaty in people a

News

GSK takes SK bio-partnered COVID jab into phase 3

As a top vaccine maker, GlaxoSmithKline has been a laggard in the COVID-19 vaccine race, but has put on a late burst of speed with a start of phase 3 trials of a second candidate that will

News

Talking vaccines: Industry’s role in protecting the Gavi generation

UK real-world study finds COVID-19 jab protection wanes

A study has found evidence that protection from the AstraZeneca and Pfizer/BioNTech COVID-19 vaccines starts fall off after a few months, but a UK government advisor says there's no need to

News

FDA grants full approval to Pfizer/BioNTech COVID jab

Pfizer and BioNTech's COVID-19 vaccine was the first to get emergency use authorisation (EUA) from the FDA, and has also become the first to get full regulatory approval in the US.

Italian 'chatbot' predicted COVID-19 spikes, says study

Targeting COVID-19 and cancer with immunotherapy advancement...

FDA schedules adcomm for Pfizer's COVID booster filing

GSK takes SK bio-partnered COVID jab into phase 3

UK real-world study finds COVID-19 jab protection wanes

FDA grants full approval to Pfizer/BioNTech COVID jab

Clock starts ticking on UK's single patient record plan

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks